Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 451 AL 465

Editorial: How Will Aducanumab Approval Impact AD Research?

Weiner MW, Aisen PS, Beckett LA, Green RC, Jagust W, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ.

J Prev Alzheimers Dis. 2021;8(4):391-392. doi: 10.14283/jpad.2021.46.

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

Lowe SL, Duggan Evans C, Shcherbinin S, Cheng YJ, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR.

J Prev Alzheimers Dis. 2021;8(4):414-424. doi: 10.14283/jpad.2021.56.

Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives

Usman MB, Bhardwaj S, Roychoudhury S, Kumar D, Alexiou A, Kumar P, Ambasta RK, Prasher P, Shukla S, Upadhye V, Khan FA, Awasthi R, Shastri MD, Singh SK, Gupta G, Chellappan DK, Dua K, Jha SK, Ruokolainen J, Kesari KK, Ojha S, Jha NK.

J Prev Alzheimers Dis. 2021;8(4):534-551. doi: 10.14283/jpad.2021.52.

Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ(1-)(40) injection in ovariectomized Alzheimer's disease model rats

Xie Y, Yan B, Hou M, Zhou M, Liu C, Sun M, He K, Fang C, Chen Y, Huang L.

Pharm Biol. 2021 Dec;59(1):1402-1414. doi: 10.1080/13880209.2021.1990353.

Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

Liu XY, Zhang N, Zhang SX, Xu P.

Eur J Neurosci. 2021 Nov;54(10):7749-7769. doi: 10.1111/ejn.15502. Epub 2021 Nov 7.

Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease

Flores-Clemente C, Nicolás-Vázquez MI, Mera Jiménez E, Hernández-Rodríguez M.

Biomolecules. 2021 Sep 26;11(10):1408. doi: 10.3390/biom11101408.

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease

Liu CS, Herrmann N, Song BX, Ba J, Gallagher D, Oh PI, Marzolini S, Rajji TK, Charles J, Papneja P, Rapoport MJ, Andreazza AC, Vieira D, Kiss A, Lanctôt KL.

BMC Geriatr. 2021 Dec 4;21(1):677. doi: 10.1186/s12877-021-02636-6.

Cardiac Biomarkers in Stroke, Alzheimer's Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations

Khan S, Kamal MA.

CNS Neurol Disord Drug Targets. 2021;20(8):687-693. doi: 10.2174/1871527319666201005171003.

Nanoconstructs as a versatile tool for detection and diagnosis of Alzheimer biomarkers

Gopalan D, Pandey A, Alex AT, Kalthur G, Pandey S, Udupa N, Mutalik S.

Nanotechnology. 2021 Apr 2;32(14):142002. doi: 10.1088/1361-6528/abcdcb.

A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease

Bouftas M.

J Prev Alzheimers Dis. 2021;8(1):84-91. doi: 10.14283/jpad.2020.57.

Dementia research in 2020: moving forward despite the COVID-19 pandemic

Kivipelto M, Mangialasche F.

Lancet Neurol. 2021 Jan;20(1):3-5. doi: 10.1016/S1474-4422(20)30453-1.

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

Moscoso A, Grothe MJ, Ashton NJ, Karikari TK, Lantero Rodríguez J, Snellman A, Suárez-Calvet M, Blennow K, Zetterberg H, Schöll M; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2021 Apr 1;78(4):396-406. doi: 10.1001/jamaneurol.2020.4986.

Polyamine biomarkers as indicators of human disease

Amin M, Tang S, Shalamanova L, Taylor RL, Wylie S, Abdullah BM, Whitehead KA.

Biomarkers. 2021 Mar;26(2):77-94. doi: 10.1080/1354750X.2021.1875506. Epub 2021 Jan 25.

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.

JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias